Profil
Jon Inge Erdal is currently the Chairman & Chief Executive Officer at ScanVacc AS.
He completed his undergraduate degree from the Norwegian University of Science & Technology in 1984.
Postes actifs de Jon Inge Erdal
| Sociétés | Poste | Début |
|---|---|---|
ScanVacc AS
 ScanVacc AS Pharmaceuticals: MajorHealth Technology ScanVacc AS develops, registers, markets, and sells pharmaceuticals for the aquaculture industry. The firm specializes in sedatives and anesthetics for the salmon farming industry. Its products include Aqui-S vet., Finquel vet., Ovaplant vet., and Aquaclam vet. for treating fish diseases such as body cavity, changes in color, behavioral, eye, fecal, fin, gallbladder, and kidney disorders. The company was founded on August 12, 1997 and is headquartered in Hvam, Norway. | Directeur Général | 01/01/2000 |
Formation de Jon Inge Erdal
| Norwegian University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ScanVacc AS
ScanVacc AS Pharmaceuticals: MajorHealth Technology ScanVacc AS develops, registers, markets, and sells pharmaceuticals for the aquaculture industry. The firm specializes in sedatives and anesthetics for the salmon farming industry. Its products include Aqui-S vet., Finquel vet., Ovaplant vet., and Aquaclam vet. for treating fish diseases such as body cavity, changes in color, behavioral, eye, fecal, fin, gallbladder, and kidney disorders. The company was founded on August 12, 1997 and is headquartered in Hvam, Norway. | Health Technology |
